Senti Biosciences Inc increased first quarter of 2023 net loss per share of $-0.42 compare to net loss per share of $-0.11 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.51 realized in previous quarter.
first quarter of 2023
Earnings Per Share
Revenues
$ -0.42
$
1 Mill
$-0.31
$+1M
Senti Biosciences Inc 's Revenue
rose by
0 % in first quarter of 2023 (Mar 31 2023) year on year,
to $1 million and
advanced by
10.67 % sequentially.
Senti Biosciences Inc is Expected to report next financial results on August 11, 2023.
Senti Biosciences Inc 's
in thefirst quarter of 2023 recorded net loss of $-18.722 million, an increase from net loss of $-3.358 million in IV. Quarter a year ago.
Sequentially
net loss narrowed from net loss of $-29.726 million realized in previous quarter.